MicroVention Terumo, owned by Japanese medical device maker Terumo Corp., is embarking on its long-term growth plan under a new name.The company, which is known for making products to treat strokes ...

Terumo Neuro won the award for best in-house legal team at the Business Journal’s 14th annual General Counsel Awards on Nov. 14 ...

Terumo Neuro's SOFIA ™ Catheter Line is Backed By 10 Years of Proven Clinical Performance1-9 and Innovation – The New SOFIA™ Flow 88 Offers Reliable Trackability, Proximal Stability and ...

As Terumo Neuro, the company is poised to continue its legacy of innovation with an enhanced focus on driving impactful growth and leveraging Terumo’s global resources and reputation.

Terumo Neuro (formerly MicroVention) has launched the SOFIA 88 Neurovascular Support Catheter commercially in the US, making a new addition to its stroke portfolio.

View today's Terumo Corp. stock price and latest 4543 news and analysis. Create real-time notifications to follow any changes in the live stock price.

Terumo Neuro's Carotid Stent System is indicated for the treatment of carotid artery stenosis in patients at increased risk for adverse events following carotid endarterectomy. The device is ...

Terumo Neuro's SOFIA ™ Catheter Line is Backed By 10 Years of Proven Clinical Performance and Innovation – The New SOFIA™ 88 Catheter Offers Reliable Trackability, Proximal Stability and ...

Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced the commercial availability of the SOFIA™ 88 Neurovascular Support ...

--Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced the commercial availability of the SOFIA™ 88 Neurovascular ...